Science Explorer Back to mapMap
Discussion
Researcher · Avera Health · United States

Brian R Leyland-Jones

Brian R Leyland-Jones publishes mostly in Oncology, Molecular Biology and Cancer Research, on topics such as HER2/EGFR in Cancer Research, Cancer Genomics and Diagnostics and Cancer Treatment and Pharmacology.

ORCID 0000-0003-2434-0774 OpenAlex
World rank
#178,132
of 7,710,434 ranked researchers
Rank in United States
#66,546
of 1,627,098
Works
431
Citations
32k
Citations per work
74.6
h-index
65
i10-index 163Top 1.7% in Oncology
Brian R Leyland-Jones

What does Brian R Leyland-Jones research?

Brian R Leyland-Jones's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (33%).

Health Sciences: 170 works · 39.4% of their workMedicine: 170 works · 39.4% of their workOncology: 113 works · 26.3% of their workPulmonary and Respiratory Medicine: 39 works · 9.0% of their workRadiology, Nuclear Medicine and Imaging: 18 works · 4.1% of their workLife Sciences: 142 works · 32.9% of their workBiochemistry, Genetics and Molecular Biology: 142 works · 32.9% of their workMolecular Biology: 69 works · 15.9% of their workCancer Research: 57 works · 13.2% of their workGenetics: 16 works · 3.8% of their workEverything else: 119 works · 27.7% of their workTHEIR WORKBrian RLeyland-Jones431works
Life Sciences33%Health Sciences39%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine17039.4%
    1. Biochemistry, Genetics and Molecular Biology14232.9%
  3. Everything else11927.7%
  1. 1Oncology26% of their works
  2. 2Molecular Biology16% of their works
  3. 3Cancer Research13% of their works
  4. 4Pulmonary and Respiratory Medicine9% of their works
  5. 5Radiology, Nuclear Medicine and Imaging4% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe Brian R Leyland-Jones's research?

The keywords of their largest research topics: Breast Cancer, Metastatic Breast Cancer, HER2, Trastuzumab, Cancer Genomics, Mutational Signatures, Cancer Therapy and Chemotherapy-Induced Peripheral Neuropathy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Breast Cancer1222 topics
  2. Metastatic Breast Cancer882 topics
  3. HER2801 topic
  4. Trastuzumab801 topic
  5. Cancer Genomics621 topic
  6. Mutational Signatures621 topic
  7. Cancer Therapy562 topics
  8. Chemotherapy-Induced Peripheral Neuropathy461 topic
  9. Taxanes461 topic
  10. Breast Tumours451 topic
  11. Gene Expression451 topic
  12. CDK4/6 Inhibitors421 topic
  13. Palbociclib421 topic
  14. BRCA Mutation321 topic
  15. PARP Inhibitors321 topic
  16. Signaling321 topic
  17. mTOR321 topic
  18. Cell Cycle241 topic
  19. p53241 topic

Where does Brian R Leyland-Jones work?

Brian R Leyland-Jones's main affiliation in the publication record is Avera Health, United States.

How many publications and citations does Brian R Leyland-Jones have?

OpenAlex counts 431 works and 32,165 citations for Brian R Leyland-Jones, an h-index of 65, ranking #178,132 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Brian R Leyland-Jones. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.